| 生物活性 | |||
|---|---|---|---|
| 描述 | The targeted inhibition of 11β-HSD1 leads to reduced blood glucose levels in hyperglycemic mice, highlighting the therapeutic potential of selective 11β-HSD1 inhibitors for addressing diseases with significant unmet medical needs, such as type 2 diabetes, obesity, and metabolic syndrome. BVT-14225 is notably effective in enzyme assays, achieving 90% inhibition at a concentration of 10 μM, and exhibits an IC50 of 52 nM against the human enzyme[2]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.49mL 0.50mL 0.25mL |
12.44mL 2.49mL 1.24mL |
24.88mL 4.98mL 2.49mL |
| 参考文献 |
|---|